Drug Type ASO |
Synonyms LNA-antimiR-122, Miravirsen sodium + [2] |
Target |
Mechanism miR-122 inhibitors(microRNA 122 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Miravirsen | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatitis C, Chronic | Phase 2 | SK | 01 Sep 2010 | |
Eye Diseases | Phase 2 | US | 01 Sep 2006 | |
Hepatitis C | Phase 2 | - | - | |
Chronic hepatitis C genotype 1 | Phase 1 | PR | 01 Nov 2012 | |
Hepatitis C, Chronic | Phase 1 | DE | 01 Sep 2010 | |
Hepatitis C, Chronic | Phase 1 | PR | 01 Sep 2010 | |
Hepatitis C, Chronic | Phase 1 | US | 01 Sep 2010 | |
Hepatitis C, Chronic | Phase 1 | PL | 01 Sep 2010 | |
Hepatitis C, Chronic | Phase 1 | NL | 01 Sep 2010 |